Vinyoflex (530401)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/E of 8.09 and P/B of 1.19 with book value of ₹77.60 provide a statistically inexpensive entry point
• Latest quarter remains profitable with ₹10 Cr sales and ₹1 Cr net profit
• ROCE of 11.02% is above ROE, indicating moderate capital efficiency at the operating level
• Small market cap of ₹40 Cr leaves room for niche operations rather than conglomerate complexity

Concerns

• Sales fell 21.64% and profit fell 18.75%, showing clear fundamental deterioration
• Piotroski F-Score of 3/9 points to weak financial health and poor operating momentum
• No dividend yield means minority shareholders get no cash return while waiting
• ROE of 8.23% is modest and commodity chemicals generally lack durable pricing power

AI Analysis

Let me start with what I like: this is cheap by basic arithmetic. At ₹92.40, Vinyoflex trades at 8.09 times earnings and just 1.19 times book, with a stated book value of ₹77.60. A P/E below 10 and P/B near one gets my attention, but Graham insisted that price is only the start. I have to ask whether the business underneath is earning an acceptable return on capital. It isn't very exciting: ROE is 8.23%, and ROCE is 11.02%. Those numbers are okay for an asset-heavy chemistry business, but they are not the kind of returns that build a durable moat. The decline is more worrying. Sales fell 21.64% and profits fell 18.75%. The latest quarter shows ₹10 crore in sales and ₹1 crore in net profit, so it is still profitable, but the trend is heading in the wrong direction. The Piotroski F-score of 3 out of 9 is a red flag; it suggests deteriorating operating efficiency, margins, or financial structure. I also see no dividend yield, so minority shareholders are entirely dependent on capital gains. In a commodity chemical company without pricing power, that is a thin margin of safety. Is this a classic Graham net-net or asset play? No. I am paying a 19% premium to book value, not a discount. More honestly, this looks like a cyclical business at a low point, with a cheap multiple that could become a value trap if earnings keep falling. I would only be interested after I see sales stabilize, margins hold, and the F-score improve. Until then, I keep it on the watchlist.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer